openPR Logo

Press Releases from Open Therapeutics (5 total)

Timmaron Group of Minnesota invests in Open Therapeutics, LLC

Open Therapeutics, LLC owns Therapoid. Therapoid is a scientific collaboration platform that crowdsources scientists, particularly the underserved in Africa, Asia, and Latin America, around freely provided Intellectual property. Therapoid not only provides IP, but grants, free lab equipment, manuscript development tools, and preprint server for achieving open access publications and pushing technology development forward. For more information about Open Therapeutics visit (https://OpenTherapeutics.org) or visit (https://Therapoid.net) to register.

Open Therapeutics Launches Strategic Partnership with The Knight Group

Open Therapeutics, a St. Paul, MN based company that curates and develops open medical, biopharma and synthetic biology-based biotechnologies, has entered into a strategic partnership with The Knight Group, a Cleveland based executive search firm specializing in scientific staffing. The Knight Group, led by CEO Ray Knight, will source talent via internal resources and Open Therapeutics’ Therapoid web platform under the auspices of a shared revenue model. “This venture,

Open Therapeutics Receives Oklahoma Medical Research Foundation’s Dormant Inte …

Open Therapeutics Receives Oklahoma Medical Research Foundation’s Dormant Intellectual Property. The intellectual property is available on the scientific collaboration platform, Therapoid™. Minneapolis, MN– August 7, 2018 – Open Therapeutics LLC, a scientific collaboration platform company, received dormant intellectual property (IP) from the Oklahoma Medical Research Foundation (OMRF). According to Jason E. Barkeloo, Founder and Chair of Open Therapeutics, “Open Therapeutics in-licenses and accepts dormant, orphan, and abandoned IP from institutions and organizations

Open Therapeutics Announced as a Winner of Freedom from Cancer Startup Challenge

Minneapolis, MN and Bethesda, MD – July 26, 2018 – Open Therapeutics LLC, a scientific collaboration platform company, is a winner of the Center for Advancing Innovation (CAI) Freedom from Cancer Startup Challenge (FCSC). The FCSC, generously supported by the Laura and John Arnold Foundation and MedImmune®, has an overarching goal to advance more than one hundred inventions to prevent, diagnose and/or treat cancer. The inventions were developed at fifty-five institutions,

Open Therapeutics and doDOC™ Partner to Integrate doDOC™ Content Management …

Open Therapeutics and doDOC™ Partner to Integrate doDOC™ Content Management System into Therapoid™. Innovative manuscript development tool to be integrated into scientific collaboration platform. Minneapolis, MN and Boston, MA – June 27, 2018 – Open Therapeutics LLC, a scientific collaboration platform company, and doDOC, a online collaborative writing tool that allows researchers to plan, draft, edit, review and approve professional documents more than 70% faster, have partnered. Therapoid™ will freely